Study to Assess Prevalence of BRCA1 and BRCA2 Mutation Among Ovarian, Primary Peritoneal and Fallopian Tube Cancer Patients in India
Clinical trial NCT03471572 · COMPLETED
Trial details
- NCT number
- NCT03471572
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-03-22
- Primary completion
- 2018-12-21
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.